Skip to main content
Figure 1 | Annals of General Psychiatry

Figure 1

From: Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series

Figure 1

Yale-Brown Obsessive Compulsive Scale (Y-BOCS) trends within 3 months of administration of agomelatine 50 mg/day in serotonin reuptake inhibitor (SRI)-refractory obsessive-compulsive disorders (OCDs). When remission occurred, it was substantial. In contrast, those refractory to agomelatine in the trial were largely unchanged within a 3 month follow-up.

Back to article page
\